Text Size
1 study found for:    nct00890162

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Conditions: Anaphylaxis;   Hypotension;   Bronchospasm;   Angioedema
Interventions: Drug: Epinephrine;   Procedure: Bone Marrow Apsiration;   Drug: Omalizumab (Xolair)
To Top

† Indicates status has not been verified in more than two years